CHEMOTHERAPEUTIC TRIALS IN PSYCHOSIS: III. ADDENDUM
Abstract
BOL in doses of 10 mg. orally 3 times daily for 4 to 5 weeks was administered to 6 chronically ill schizophrenic women. This abolished the response to LSD up to 200 gamma but failed to alter the psychosis in any way. Initial doses of 10 mg. BOL may produce mild LSD-like reactions.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).